← Eichor
Study identifier: NCT06760273 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

Condition: Bronchiectasis Adult  ·  Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

PhaseN/A
Planned participants364
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The ERASE II study is a prospective follow-up study designed to assess the long-term impact of successful eradication of Pseudomonas aeruginosa (PA) in patients with bronchiectasis. Building on the findings of the initial ERASE study, which evaluated the efficacy and safety of Tobramycin Inhalation Solution, ERASE II aims to determine whether successful PA eradication influences patient prognosis over an extended period. The study will involve a total observation period of 36 months, consisting of the initial 9 months of the ERASE study followed by an additional 27 months of comprehensive follow-up. Key outcomes to be assessed include patients' quality of life, lung function, frequency of pulmonary exacerbations, frequency of hospitalization, and overall treatment costs. Additionally, the study will examine the timing and incidence of any potential reinfections with Pseudomonas aeruginosa.

This description comes directly from the study's public registry record.

Talk to the study team

Jin-Fu Xu  ·  +8613321922898  ·  jfxucn@163.com

Jin-Fu Xu, PhD  ·  +8613321922898  ·  jfxucn@163.com

Always discuss trial participation with your own doctor first.

Locations (58)

Anhui Chest HospitalHefei, Anhui, ChinaRecruiting
The First Affiliated Hospital of Anhui Medical UniversityHefei, Anhui, ChinaRecruiting
Beijing Chao-Yang Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
Peking Union Medical College Hospital, Chinese Academy of Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting
The Second Affiliated Hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaActive Not Recruiting
The Third Affiliated Hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaRecruiting
Fujian Provincial HospitalFuzhou, Fujiang, ChinaRecruiting
The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, Guangdong, ChinaRecruiting
The First Affiliated Hospital of Guangzhou University of Traditional Chinese MedicineGuangzhou, Guangdong, ChinaRecruiting
Shenzhen Institute of Respiratory DiseasesShenzhen, Guangdong, ChinaRecruiting
The Eighth Affiliated Hospital of Sun Yat-Sen UniversityShenzhen, Guangdong, ChinaRecruiting
Affiliated Hospital, Guangdong Medical CollegeZhanjiang, Guangdong, ChinaActive Not Recruiting

+ 46 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06760273